ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,343,000 | -34.6% | 7,807 | -52.3% | 0.01% | -36.4% |
Q2 2021 | $2,054,000 | +82.4% | 16,368 | +97.2% | 0.02% | +57.1% |
Q1 2021 | $1,126,000 | +72.4% | 8,300 | +62.7% | 0.01% | +55.6% |
Q4 2020 | $653,000 | -68.1% | 5,100 | -76.2% | 0.01% | -66.7% |
Q2 2020 | $2,044,000 | +34.7% | 21,452 | -25.0% | 0.03% | -27.0% |
Q4 2019 | $1,517,000 | +36.2% | 28,611 | +1.5% | 0.04% | +12.1% |
Q3 2019 | $1,114,000 | -79.3% | 28,200 | -80.4% | 0.03% | -93.3% |
Q3 2017 | $5,375,000 | +2050.0% | 144,017 | +1429.0% | 0.49% | +1864.0% |
Q1 2017 | $250,000 | – | 9,419 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |